Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2009
The purpose of this study is to assess the efficacy, pharmacokinetics, safety, and immunogenicity of abatacept after subcutaneous and intravenous administration in Japanese participants with active rheumatoid arthritis and inadequate response to methotrexate.
Epistemonikos ID: 4aeb999d80f725ca8582ac2c41555c1e19b0ea57
First added on: Mar 23, 2022